Literature DB >> 3396151

Comparative in vitro cytotoxicities of adriamycin (ADM) and 4'[(9-acridinyl)-amino] methane sulphon-m-anisidide (mAMSA)

B T Hill, R D Whelan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3396151     DOI： 10.1007/bf00254190

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  5 in total

1.  The value of adriamycin in overcoming resistance to methotrexate in tissue culture.

Authors:  B T Hill; L A Price; J H Goldies
Journal:  Eur J Cancer       Date:  1976-07       Impact factor: 9.162

2.  In vitro responses of human prostate tumour cell lines to a range of antitumour agents.

Authors:  S A Metcalfe; R D Whelan; J R Masters; B T Hill
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

3.  Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screening.

Authors:  B T Hill; R D Whelan; L K Hosking
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

4.  Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.

Authors:  B T Hill; S A Whatley; A S Bellamy; L Y Jenkins; R D Whelan
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

5.  A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.

Authors:  C M West; I J Stratford
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.